Finance entity
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Buprenorphine, the most common co-covered peer. Source depth averages 4 original sources per story, versus 2.3 across the same-window beat baseline.
Last mentioned: 1h ago
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Buprenorphine, the most common co-covered peer. Source depth averages 4 original sources per story, versus 2.3 across the same-window beat baseline. Their average consequence score of 6 runs below the beat's 6.2 for that window. Methadone appears in 1 tracked Finance story from September 12, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 42 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Methadone. Shared-story counts are live from our verified record — not editorial picks.
For investors, the methadone clinic system is a textbook regulatory-moat business: daily-visit, publicly reimbursed recurring revenue owned by private-equity-backed and publicly traded chains. The investigation highlights why the moat that made it attractive is now a political risk as lawmakers scrutinize private-equity ownership in addiction care.
Methadone is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
